Boostrix tdap vaccine syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FBTQ5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,465
Award facts
- Contract value 100% obligated
- $21,465.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,465.42 to AmerisourceBergen Drug Corp for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This firm fixed-price, non-set-aside delivery order was awarded on January 27, 2026, with an ultimate completion date of January 28, 2026. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999 through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company has demonstrated extensive capability in fulfilling federal medical supply needs through its diverse contract portfolio with the DLA, which includes vaccines, generic and brand-name medications, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This vaccine delivery supports the Defense Health Agency and other government healthcare systems in maintaining critical immunization supplies for military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FBTQ5?
SPE2DR26FBTQ5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FBTQ5 worth?
The government has obligated $21,465 on SPE2DR26FBTQ5.
Is contract SPE2DR26FBTQ5 an order under another contract?
Yes. SPE2DR26FBTQ5 is a delivery order under SPE2DR25D2002, an indefinite delivery contract.
Was contract SPE2DR26FBTQ5 competed?
The extent of competition for SPE2DR26FBTQ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award